H.E. Dawood Al Shezawi Chairman of AIM Congress SHANGHAI, Nov. 04, 2025 (GLOBE NEWSWIRE) — The Annual Investment Meeting (AIM) Congress, the world’s leading platform for investment and economic cooperation, will host its first-ever international chapter in Shanghai, China, marking a major expansion of AIM’s global presence. This milestone reinforces AIM’s mission to connect markets, promote innovation, and accelerate sustainable economic growth through international collaboration. Held under the theme “Deciphering the Intertwined Engines of Globalization: ‘From Going Out’ to ‘Going Up’,” the forum will explore how industries and economies can evolve through technology integration, sustainability, and investment-driven transformation. The event will bring together 85 distinguished speakers in 15 high-level sessions, drawing more than 1,000 participants from over 150 nationalities —including investors, entrepreneurs, and industry leaders. Discussions will address global investment trends, sustainable finance, and digital transformation shaping the future of business. H.E. Dawood Al Shezawi, Chairman of AIM Congress, stated: “AIM Congress China Chapter represents more than an expansion; it is a milestone in our journey to bridge markets and ideas across continents. Shanghai stands as a beacon of progress and innovation, making it the ideal host city for a platform that embodies forward-looking investment dialogue and mutual cooperation. Together, we aim to redefine the contours of globalization by building economies that are resilient, inclusive, and future-ready.” The two-day program will feature insights from leading voices, including H.E. Dr. Thani bin Ahmed Al-Zeyoudi, UAE Minister of Foreign Trade; H.E. Raja Al Mazrouei, CEO of Etihad Credit Insurance; H.E. Omar Suwaina Al Suwaidi, Undersecretary of UAE Ministry of Industry and Advanced Technology, Pu Yapeng, Vice Chairman of the Shanghai Municipal Commission of Economy and Informatization; and Rae Kwon Chung, Nobel Laureate and Ambassador of Climate Change, among others. In addition to its conference sessions, AIM Congress China Chapter will host strategic partnerships and collaboration signings among major institutions, including the Beijing Chamber of International Commerce (BCIC), China Council for the Promotion of International

New Quantexa AI capabilities give enterprises and government agencies the trusted data and contextual intelligence required to deploy agentic AI safely, at scale, and with confidence LONDON, Nov. 04, 2025 (GLOBE NEWSWIRE) — In a major leap forward for enterprise AI, Quantexa, a global pioneer in Decision Intelligence, has unveiled Quantexa AI, the next evolution of its flagship Decision Intelligence Platform, now fully agentic ready. As organizations accelerate their use of large language models (LLMs) and smaller, purpose-built and domain-trained models, many are discovering a common limitation: when AI interacts with fragmented or untrusted data, it can amplify inaccuracies, make flawed decisions, and create costly feedback loops. Whether using general models or specialized ones, enterprises can only achieve accurate, explainable, and auditable outcomes when AI is grounded in trusted, contextualized data that reflects the complete view of the business. Securely accessing and contextualizing enterprise data for AI has prompted many organizations to rethink their AI deployments and their broader data and operating models. The breakthrough with Quantexa AI lies in its ability to democratize and operationalize contextualized enterprise data that can interact bidirectionally with both LLMs and task-specific models using open industry standards. This innovation enables humans and AI agents alike to converse with data in context, combining the reasoning power of LLMs with the precision of specialized models, so they can act and decide confidently and responsibly in real time. It represents the next evolution in helping organizations leverage AI safely and effectively to serve customers better, mitigate risk, and drive operational efficiency. Quantexa AIQuantexa AI connects every layer of intelligence, from foundational data unification to reasoning and action, in one governed environment. Introducing Quantexa AI: Trusted, Contextual, and Agentic Unlike conventional analytics tools or model platforms that can operate in isolation, Quantexa AI connects every layer of intelligence,

Nyxoah to Participate in the Stifel 2025 Healthcare Conference Mont-Saint-Guibert, Belgium – November 3, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Stifel 2025 Healthcare Conference on Tuesday, Nov. 11, 2025. The Company is scheduled to present at 9:20am Eastern Time the same day via webcast. A live webcast of the event can be accessed by visiting Nyxoah’s Investor Relations website and will be available for replay following the events. The Company will also be available for 1×1 meetings with institutional investors attending the event. About Nyxoah Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest. Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study and U.S. FDA approval of a Premarket Approval application. Caution – CE marked since 2019. FDA approved in August 2025 as prescription-only device. FORWARD-LOOKING STATEMENTS Certain statements, beliefs and opinions in this press

LONDON, Nov. 03, 2025 (GLOBE NEWSWIRE) — Professor Spyridon Flogaitis, an internationally renowned legal scholar, jurist, and public servant, has been announced as the recipient of the 2025 Global Citizen Award. He is the Director and President of the Board of the European Public Law Organization (EPLO), an institution fostering legal reform and civic values across continents. This annual tribute, presented by leading international residence and citizenship advisory firm Henley & Partners in partnership with the Swiss non-profit humanitarian organization Andan Foundation, recognizes his lifelong commitment to strengthening democratic institutions, the rule of law, and legal access for vulnerable communities. The prestigious award, which honors an individual who shows exceptional courage and commitment towards improving and supporting the global community, was presented at a gala reception during the 19th annual Global Citizenship Conference in London, which brought together prime ministers, ambassadors, senior government officials, and leading academics, as well as top-tier private client advisors and wealth management professionals. Professor Flogaitis received the Global Citizen Award for his tireless work in advancing public law, legal education, and institutional reform, particularly in regions facing democratic fragility and post-crisis recovery. As Director and President of the Board of the European Public Law Organization (EPLO), he has led groundbreaking initiatives to improve local governance, train civil servants, and increase access to justice for marginalized groups. His efforts have had lasting impact in Southeastern Europe and beyond, fostering legal frameworks that uphold human rights and enable civic participation. Chairman of Henley & Partners and Founder of the Andan Foundation, Dr. Christian H. Kaelin, praised the awardee’s outstanding contributions. “Professor Flogaitis has demonstrated how the law can be a transformative force for peace, dignity, and inclusion. His commitment to justice, democratic resilience, and cross-border collaboration exemplifies what it means to be a global citizen. We are honored to recognize a leader whose intellect and integrity have